Sign up to our newsletter

Since 1994, Hytest has systematically studied the biochemical and immunochemical properties of cardiac troponins and has developed comprehensive antibody selection strategies for cTnI and cTnT assay development, backed by a strong scientific foundation. In 2004, Hytest’s cardiac troponin complex was chosen as a raw material for the international troponin standard. Through all these years, we have been providing highly specific and sensitive antibodies and antigens for the development of your immunological assays.  

Greetings from CACLP 2025! Team Hytest had a fantastic time meeting clients and industry professionals in Hangzhou, China. CACLP continues to be an incredible event, bringing together all branches of the IVD industry for innovation and inspiration. 

Each March, the Brain Injury Association of America recognizes Brain Injury Awareness Month, dedicated to raising awareness for individuals affected by brain injuries and their caregivers. Blue is the official color of the awareness campaign, symbolizing strength, resilience, and hope.

NT-proBNP is one of the most valuable biomarkers for heart failure (HF). Its clinical value includes the diagnosis of HF, assessment of disease severity and prognosis, monitoring of cardiac function, and supporting the evaluation of acute coronary syndrome (ACS). 

This holiday season, we’re happy to continue our partnership with Gubbe to bring joy to elderly people.The loneliness of elderly people is a real problem in Finland, and we want to be a part of the solution. Gubbe offers help and companionship to the elderly, while also providing meaningful part-time jobs to young adults.

We are proud to sponsor the EFLM Cardiac Marker Award, which recognizes remarkable scientific work in the field of cardiovascular diseases. This award, presented by the European Federation of Laboratory Medicine (EFLM), honors the best original research paper on cardiac marker measurements and cardiovascular risk assessment.

Join us for an insightful webinar on cardiac troponins, featuring Dr. Allan Jaffe as the keynote speaker and Dr. Ivan Katrukha as the featured speaker.

Strong bones are the foundation of overall good health, yet bone health issues often go undetected until an unexpected disease starts to show its prevalence.

All Hytest SARS-CoV-2 nucleoprotein (NP) antibodies (Cat. #3CV4), including monoclonal antibodies (MAbs) C706, C524, C518, C715, and C527, target the N-terminal part of the nucleoprotein, specifically the region N47-A173. 

We will be attending Medica 2024 in mid-November.

Cardiac troponins I (cTnI) and T (cTnT) are established biomarkers of acute myocardial infarction (AMI). Together with troponin С (TnC), they form a ternary troponin complex (ITC-complex) that represents a significant portion of troponins released into the bloodstream following cardiomyocyte necrosis

In this latest article, the authors further discuss the effects of heparin on the measurement of cardiac isoforms of cTnI and cTnT.

As we celebrate our 30th anniversary, Hytest is proud to offer a special opportunity to our valued customers. Experience the reliability of our tumor markers.This exclusive offer is our way of saying thank you for your continued tr As we celebrate our 30th anniversary, Hytest is proud to offer a special opportunity to our valued customers. Experience the reliability of our tumor markers.This exclusive offer is our way of saying thank you for your continued trust and support. ust and support.

To help find better solutions in tackling tumor cancers investigations, we are very much delighted to announce that our new product, mouse monoclonal antibody (MAb) 1X5cc is launched today!

In collaboration with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the European Federation of Laboratory Medicine (EFLM), Hytest has proudly demonstrated its commitment to advancing scientific research in the field of cardiovascular diseases. By sponsoring awards, Hytest has consistently recognized and honoured outstanding work in cardiovascular diagnostics. 

We will be attending the 2024 ADLM Clinical Lab Expo from July 28 to August 1.

By choosing to buy locally, you not only support the North American branch but also ensure a smoother, more cost-effective purchasing experience.

We are excited to announce the launch of a new recombinant Anti-CA-125 antibody RX16 (Cat# 4C29).

May is Cancer Survivor Month. We honor the strength, resilience, and courage of cancer survivors around the world.